Nucleotide oligomerization domain 2 polymorphisms in patients with intestinal failure

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 2, 2013, Pages 309-313

  Guerra, Juan Francisco ^a,b   Zasloff, Michael ^a   Lough, Denver ^a   Abdo, Joseph ^a   Hawksworth, Jason ^a   Mastumoto, Cal ^a   Girlanda, Raffaele ^a   Island, Eddie ^a   Shetty, Kirty ^a   Kaufman, Stuart ^a   Fishbein, Thomas ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Innate immunity; Intestinal failure; Intestinal homeostasis; NOD2 polymorphisms

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FOLLOW UP; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; INFANT; INTESTINAL FAILURE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84872798397     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12037     Document Type: Article

References (38)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
2. Zasloff M. Antimicrobial peptides in health and disesase. N. Engl. J. Med. 2002; 347: 1199-1200.
3. Magalhaes JG, Tattoli I, Girardin SE. The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin. Immunol. 2007; 19: 106-115.
4. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292: 1115-1118.
5. Strober W, Murray PJ, Kitani A etal. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 2006; 6: 9-20.
6. Ogura Y, Lala S, Xin W etal. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003; 52: 1591-1597.
7. Ogura Y, Inohara N, Benito A etal. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 2001; 276: 4812-4818.
8. Barnich N, Aguirre JE, Reinecker HC etal. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J. Cell Biol. 2005; 170: 21-26.
9. Lécine P, Esmiol S, Métais JY etal. The NOD2-RICK complex signals from the plasma membrane. J. Biol. Chem. 2007; 282: 15197-15207.
10. Hugot JP, Chamaillard M, Zouali H etal. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
11. Ogura Y, Bonen DK, Inohara N etal. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
12. Strober W, Kitani A, Fuss I etal. The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol. 2008; 1 (Suppl. 1): S5-9.
13. Rosenstiel P, Schreiber S. NOD-like receptors-pivotal guardians of the immunological integrity of barrier organs. Adv. Exp. Med. Biol. 2009; 653: 35-47.
14. Yamamoto S, Ma X. Role of Nod2 in the development of Crohn's disease. Microbes Infect. 2009; 11: 912-918.
15. Wehkamp J, Koslowski M, Wang G etal. Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease. Mucosal Immunol. 2008; 1 (Suppl. 1): S67-74.
16. Economou M, Trikalinos TA, Loizou KT etal. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am. J. Gastroenterol. 2004; 99: 2393-2404.
17. Lesage S, Zouali H, Cézard JP etal. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 2002; 70: 845-857.
18. Hugot JP, Zaccaria I, Cavanaugh J etal. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am. J. Gastroenterol. 2007; 102: 1259-1267.
19. Gearry RB, Roberts RL, Burt MJ etal. Effect of Inflammatory Bowel Disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm. Bowel Dis. 2007; 13: 1220-1227.
20. Fishbein T, Novitskiy G, Mishra L etal. NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 2008; 57: 323-330.
21. Fishbein T. Intestinal transplantation. N. Engl. J. Med. 2009; 361: 998-1008.
22. Ningappa M, Higgs BW, Weeks DE etal. NOD2 gene polymorphism rs2066844 associates with need for combined Liver-Intestine Transplantation in children with Short-Gut Syndrome. Am. J. Gastroenterol. 2011; 106: 157-165.
23. Fishbein TM, Matsumoto CS. Intestinal replacement therapy: timing and indications for referral of patients to an intestinal rehabilitation and transplant program. Gastroenterology 2006; 2 (Suppl. 1): S147-151.
24. O'Keefe SJ, Buchman AL, Fishbein TM etal. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin. Gastroenterol. Hepatol. 2006; 4: 6-10.
25. Abraham C, Cho JH. Functional consequences of NOD2 (CARD15) mutations. Inflamm. Bowel Dis. 2006; 12: 641-650.
26. Henckaerts L, Vermeire S. NOD2/CARD15 disease associations other than Crohn's disease. Inflamm. Bowel Dis. 2007; 13: 235-241.
27. Miceli-Richard C, Lesage S, Rybojad M etal. CARD15 mutations in Blau syndrome. Nat. Genet. 2001; 29: 19-20.
28. Kanazawa N, Okafuji I, Kambe N etal. Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 2005; 105: 1195-1197.
29. Kutikhin AG. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Hum. Immunol. 2011; 72: 955-968.
30. Landfried K, Bataille F, Rogler G etal. Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clin. Exp. Immunol. 2010; 159: 87-92.
31. Penack O, Smith OM, Cunningham-Bussel A etal. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J. Exp. Med. 2009; 206: 2101-2110.
32. Mayor NP, Shaw BE, Hughes DA etal. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J. Clin. Oncol. 2007; 25: 4262-4269.
33. Elmaagacli AH, Koldehoff M, Hindahl H etal. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006; 81: 247-254.
34. Dickinson AM, Middleton PG, Rocha V etal. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br. J. Haematol. 2004; 127: 479-490.
35. Holler E, Rogler G, Herfarth H etal. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004; 104: 889-894.
36. Brenmoehl J, Herfarth H, Glück T etal. Genetic variants in the NOD2/CARD15 gene are associated with early mortality in sepsis patients. Intensive Care Med. 2007; 33: 1541-1548.
37. Zouali H, Bonnard A, De Lagausie DL etal. CARD15/NOD2 is not a predisposing factor for necrotizing enterocolitis. Dig. Dis. Sci. 2005; 50: 1684-1687.
38. Madisch A, Hellmig S, Schreiber S etal. NOD2/CARD15 gene polymorphisms are not associated with collagenous colitis. Int. J. Colorectal Dis. 2007; 22: 425-428.